Dixon of the Department of Health and Human Services. “Providers participating in federal health care programs are obligated to obey the laws meant to protect the integrity of those programs and the quality of care furnished to patients,” said Special Agent in Charge Maureen R. “This office will continue to pursue cases where providers have failed to honor these rules, which were established to provide quality care to elderly citizens and military veterans, among others.”
Romero for the Eastern District of Pennsylvania. “Providers must act within clear federal healthcare program boundaries to ensure that appropriate care is given to the beneficiaries of those programs,” said U.S. Boynton, head of the Justice Department’s Civil Division. “Today’s settlement reminds all providers that they must observe those standards and reflects the department’s commitment to pursue knowing violations of federal health care program requirements.” “Federal health care beneficiaries deserve care, including remote cardiac monitoring, that complies with federal law and is provided by qualified clinical personnel,” said Principal Deputy Assistant Attorney General Brian M. Although BioTelemetry began implementing technological controls in late 2015 to prevent personnel in India from accessing the domestic workflow, those controls were insufficient, and technicians in India allegedly continued to review and analyze some ECG Data for federal healthcare program beneficiaries thereafter. In 2015, those numbers allegedly rose to over 47% and over 88%, respectively. In 2014, over 29% of the ECG Data reviewed in connection with MCT tests, and over 78% of the ECG Data reviewed in connection with event monitoring tests, for Medicare patients were allegedly reviewed by technicians located in India. BioTelemetry also allegedly sent ECG data for other federal beneficiaries directly to India for review. Although BioTelemetry set up a workflow that was designed to route electrocardiogram data, including data relating to cardiac events (ECG Data) for federal healthcare beneficiaries, to a domestic independent diagnostic testing facility for review and analysis, the government alleged that BioTelemetry - with the knowledge of then senior management - diverted certain federal beneficiaries’ ECG Data to India when the domestic workflow became backlogged. More specifically, the government alleged that, in 2013, CardioNet contracted with a company located in India for the provision of diagnostic and analysis services of heart monitoring data. The United States alleged that CardioNet improperly billed Medicare and other federal health care programs for certain cardiac monitoring services - including Holter, event monitoring, and mobile cardiovascular telemetry (MCT) tests - that were performed overseas in violation of federal law that prohibits payment for services furnished outside the United States. and its subsidiary CardioNet LLC, both headquartered in Pennsylvania (collectively “BioTelemetry”), have agreed to pay $44,875,000 to resolve allegations that they violated the False Claims Act by knowingly submitting claims to Medicare, TRICARE, the Veterans Health Administration, and the Federal Employee Health Benefits Program for heart monitoring tests that were performed, in part, outside the United States, and in many cases by technicians who were not qualified to perform such tests.
#Biotel heart monitor Patch
In addition, the company said the study showed that using an MCOT patch followed by ILR in half of patients initially undiagnosed with AF leads to an overall cost-of-care savings of more than $4M.BioTelemetry Inc.The study also showed that use of initial MCOT monitoring achieved almost eight times lower costs, reducing the total cost per patient with detected AF by ~$199K, compared to monitoring with ILR alone.The company said the study determined that a 30-day continuous monitoring program using the Philips BioTel Heart MCOT (mobile cardiac outpatient telemetry) patch, followed by an implantable loop recorder (ILR), improved AF detection rates and helped to reduce secondary stroke risk due to new anticoagulant use in people with the MCOT patch detected AF.AF is an irregular and rapid heart rhythm that can increase risk of stroke.Royal Philips (NYSE: PHG) said a study suggested that its BioTel Heart MCOT patch detected 4.6 times more patients with atrial fibrillation (AF) compared to implantable loop recorder alone.
0 kommentar(er)
